CellSource Co Stock

CellSource Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of CellSource Co (4880.T) as of Jul 21, 2026 is 46.62. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 60.17 — a change of -22.52% (lower).

EV/EBIT

46.62

YoY

-22.52%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of CellSource Co is 2026 46.62 . EV/EBIT (Enterprise Value to EBIT) of CellSource Co was 2025 60.17 . It decreases by -22.52% lower compared to the previous year.

The CellSource Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
50.14 base
Jan 1, 2020
166.66 base
Jan 1, 2021
105.09 base
Jan 1, 2022
48.98 base
Jan 1, 2023
20.17 base
Jan 1, 2024
128.16 base
Jan 1, 2025
47.42 base
Jan 1, 2026 (e)
0.00 base
YEARPRICE-TO-EBIT
2026 est -
2025 47.42
2024 128.16
2023 20.17
2022 48.98
2021 105.09
2020 166.66
2019 50.14
2018 -
2017 -
Access this data via the Eulerpool API
Get Free API Key

CellSource Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides CellSource Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates CellSource Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots CellSource Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if CellSource Co grows earnings faster than its peers.

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

EV/EBIT (Enterprise Value to EBIT) of CellSource Co is 46.62 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — CellSource Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — CellSource Co